The immunostimulatory effect of novel immunostimulator CH2b with a thiazolidin-4-one ring on the functions of LPS-activated RAW 264.7 macrophages in vitro

被引:8
作者
Li, Chunxiao [1 ]
Meng, Ming [1 ]
Chen, Dongzhi [1 ]
Wang, Zerui [1 ]
Han, Hua [1 ]
Chen, Hua [2 ]
Zhang, Jinchao [2 ]
Li, Xiaoliu [2 ]
机构
[1] Hebei Univ, Dept Immunol, Sch Med, Baoding 071002, Hebei Province, Peoples R China
[2] Hebei Univ, Key Lab Chem Biol Hebei Prov, Coll Chem & Environm Sci, Baoding 071002, Hebei Province, Peoples R China
关键词
Immunostimulator; RAW; 264.7; iNOS; NF-kappa B; p38; MAPK; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NITRIC-OXIDE; NK-CELLS; PATHOGENESIS; MATURATION; CYTOKINES; PATHWAYS; PROMOTE; PORCINE;
D O I
10.1016/j.intimp.2013.08.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
This study was designed to confirm the effect of the novel immunostimulators CH1b and CH2b with a thiazolidin-4-one ring on the function of macrophages. We used these two molecules to stimulate LPS-activated RAW 264.7 macrophages in vitro. After a series of essential assays, we found that CH1b and CH2b could significantly increase the production of nitric oxide (NO) by the LPS-activated RAW 264.7 macrophages, and also found that CH2b could more significantly increase the proliferation, phagocytic activity, and secretion of IL-6, IL-8 and TNF-alpha by LPS-activated RAW 264.7 cells more than CH1b. Furthermore, CH2b could increase the degradation of I kappa B-alpha and could promote the nuclear translocation of nuclear factor (NF)-kappa B p65 in LPS-activated RAW 264.7 cells. However, CH2b could also increase the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK). Taken together, we got that CH2b could further increase the LPS-induced activation of NF-kappa B and p38 MAPK in RAW 264.7 macrophages to elevate the function of macrophages, including iNOS expression, NO production, cytokines secretion, and phagocytosis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:698 / 703
页数:6
相关论文
共 30 条
[1]
MHC class II signaling in antigen-presenting cells [J].
Al-Daccak, R ;
Mooney, N ;
Charron, D .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :108-113
[2]
Baxevanis CN, 2000, EUR J IMMUNOL, V30, P1957, DOI 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO
[3]
2-7
[4]
Membrane dynamics in phagocytosis [J].
Booth, JW ;
Trimble, WS ;
Grinstein, S .
SEMINARS IN IMMUNOLOGY, 2001, 13 (06) :357-364
[5]
CYTOKINES AND MACROPHAGES [J].
CAVAILLON, JM .
BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (10) :445-453
[6]
Synthesis of C-Pseudonucleosides Bearing Thiazolidin-4-one as a Novel Potential Immunostimulating Agent [J].
Chen, Hua ;
Yin, Qingmei ;
Li, Chunxiao ;
Wang, Enkai ;
Gao, Fang ;
Zhang, Xiaobo ;
Yin, Zhi ;
Wei, Sinan ;
Li, Xiaoliu ;
Meng, Ming ;
Zhang, Pingzhu ;
Li, Na ;
Zhang, Jinchao .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (11) :845-848
[7]
Molecular inflammation: Underpinnings of aging and age-related diseases [J].
Chung, Hae Young ;
Cesari, Matteo ;
Anton, Stephen ;
Marzetti, Emanuele ;
Giovannini, Silvia ;
Seo, Arnold Young ;
Carter, Christy ;
Yu, Byung Pal ;
Leeuwenburgh, Christiaan .
AGEING RESEARCH REVIEWS, 2009, 8 (01) :18-30
[8]
EVANS CH, 1995, AGENT ACTION SUPPL, V47, P107
[9]
IMMUNOSTIMULANTS (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 169-174, 1993) [J].
HADDEN, JW .
IMMUNOLOGY TODAY, 1993, 14 (06) :275-280
[10]
Hoshino K, 1999, J IMMUNOL, V162, P3749